CK

Chirag Kanubhai Patel

Director Director DIN 01989805 India's Richest · #361
DIN 01989805 First appointment Apr 2006 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Apr 2006
Shareholding value β€’β€’β€’β€’ Premium profile

About Chirag Kanubhai Patel

Data last updated:

Chirag Kanubhai Patel was a Director at Amneal Pharmaceuticals Private Limited (2006–2008). The company operates in Pharma.

Chirag Patel is #361 among India's richest people (2026), with wealth of ₹10,300 Cr.

DIN 01989805
Primary Designation Director
Industry Pharma
First Appointment 07 Apr 2006

Recognitions & Rankings

India's Richest People 2026 edition · Source: Hurun India
Rank#361
Wealth
₹10,300 Cr
Company
Amneal Pharmaceuticals
2018 #283

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Apr 20062006₹2,945 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Amneal Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Chirag Kanubhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chirag Kanubhai Patel

Chirag Kanubhai Patel was first appointed on 07 Apr 2006 as Director at Amneal Pharmaceuticals Private Limited.

Chirag Kanubhai Patel held 1 earlier board appointment: Amneal Pharmaceuticals Private Limited (Director, 07 Apr 2006 to 07 Jan 2008).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available